- Home
- PESI vs CLYM Comparison
PESI vs CLYM Comparison
Compare PESI & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- CLYM
- Stock Information
- Founded
- PESI 1990
- CLYM 2018
- Country
- PESI United States
- CLYM United States
- Employees
- PESI N/A
- CLYM N/A
- Industry
- PESI Environmental Services
- CLYM
- Sector
- PESI Industrials
- CLYM
- Exchange
- PESI Nasdaq
- CLYM NYSE
- Market Cap
- PESI 191.9M
- CLYM 201.7M
- IPO Year
- PESI 1992
- CLYM 2021
- Fundamental
- Price
- PESI $10.95
- CLYM $1.95
- Analyst Decision
- PESI Strong Buy
- CLYM
- Analyst Count
- PESI 1
- CLYM 0
- Target Price
- PESI $18.00
- CLYM N/A
- AVG Volume (30 Days)
- PESI 132.7K
- CLYM 667.9K
- Earning Date
- PESI 03-12-2025
- CLYM 11-12-2024
- Dividend Yield
- PESI N/A
- CLYM N/A
- EPS Growth
- PESI N/A
- CLYM N/A
- EPS
- PESI N/A
- CLYM N/A
- Revenue
- PESI $67,134,000.00
- CLYM N/A
- Revenue This Year
- PESI N/A
- CLYM N/A
- Revenue Next Year
- PESI $52.66
- CLYM N/A
- P/E Ratio
- PESI N/A
- CLYM N/A
- Revenue Growth
- PESI N/A
- CLYM N/A
- 52 Week Low
- PESI $7.63
- CLYM $1.73
- 52 Week High
- PESI $16.25
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- PESI 45.42
- CLYM N/A
- Support Level
- PESI $10.71
- CLYM N/A
- Resistance Level
- PESI $11.05
- CLYM N/A
- Average True Range (ATR)
- PESI 0.47
- CLYM 0.00
- MACD
- PESI 0.12
- CLYM 0.00
- Stochastic Oscillator
- PESI 67.46
- CLYM 0.00
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.